Medley Pharmaceuticals
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Vogli-GM 1 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Vogli-GM 1 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Vogli-GM 1 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Vogli-GM 1 Tablet SR.
Vogli-GM 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Vogli-GM 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Vogli-GM 1 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Vogli-GM 1 Tablet SR is a combination of three medicines: Glimepiride, Metformin, and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meals) glucose levels in the body.
Common side effects associated with Vogli-GM 1 Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Patients with known allergies to any of the components or excipients of this medicine must avoid taking Vogli-GM 1 Tablet SR. The use of this medicine is also avoided in patients with moderate to severe kidney disease and inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, alcohol should not be consumed concurrently with Vogli-GM 1 Tablet SR. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, the use of Vogli-GM 1 Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This risk is higher if you miss meals, consume alcohol, engage in strenuous exercise, or take other antidiabetic medications concurrently. Regular monitoring of blood glucose levels is crucial.
Store this medication in its original packaging, tightly closed, in accordance with the instructions provided on the label or package. Do not discard unused medicine. Ensure that it is out of reach of pets, children, and other individuals.